Table 2 COVID-19 exposure, vaccination and brand preference
Proportion (%) of all respondents | |
|---|---|
Covid case/s in the family | 33.46 |
Covid death/s in the family | 3.54 |
Covid case/s among relatives and friends | 74.02 |
Covid death/s among relatives and friends | 38.39 |
Preferred vaccine brand | |
Pfizer | 48.62 |
Moderna | 15.55 |
Johnson&Johnson | 6.50 |
Sinovac | 6.10 |
Astra Zeneca | 5.71 |
Sputnik | 0.59 |
Sinopharm | 0.20 |
No preference | 16.73 |
Vaccinated respondent | 96.26 |
Vaccine provider, n = 489 | |
Government | 88.14 |
Non-government | 11.86 |
Vaccine brand | |
Sinovac | 45.40 |
Astra Zeneca | 23.31 |
Pfizer | 16.77 |
Moderna | 11.04 |
Johnson&Johnson | 2.05 |
Sputnik | 1.43 |